Sodium Oxybate for Fibromyalgia Rejected By FDA Panel
Links shared publicly online about this topic
FDA Panel Says No to Sodium Oxybate for Fibromyalgia - QualityPoint Technologies
qualitypointtech.net — “A joint FDA advisory committee has voted against approval of sodium oxybate for fibromyalgia. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on August 23, 2010 at 12:36 pm By:
FDA Panel Says No to Sodium Oxybate for Fibromyalgia: A joint FDA advisory committee has voted against approval of... http://bit.ly/cyQMki
FDA Panel Roundly Rejects CNS Drug for Fibromyalgia - QualityPoint Technologies
qualitypointtech.net — “BETHESDA, Md. (MedPage Today) -- A federal advisory panel has voted 20-2 to recommend that the FDA not grant approval for an expanded indication for sodium oxybate (Xyrem) -- also known as GHB -- to treat fibromyalgia.” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2010 at 11:57 pm By:
FDA Panel Roundly Rejects CNS Drug for Fibromyalgia: BETHESDA, Md. (MedPage Today) -- A federal advisory panel has... http://bit.ly/beJXWE
FDA Rejects Xyrem As Fibromyalgia Treatment - Health News - redOrbit
redorbit.com — “A Food and Drug Administration (FDA) advisory panel on Friday significantly rejected the application of Jazz Pharmaceuticals for the approval of Xyrem (sodium oxybate) for the treatment of fibromyalgia.” View full resource at redorbit.com
Most Recently Shared on August 22, 2010 at 5:09 pm By:
FDA Rejects Xyrem As Fibromyalgia Treatment: A Food and Drug Administration (FDA) advisory panel on Friday signifi... http://bit.ly/b0K01V
Medical News: FDA Rejects GHB for Fibromyalgia - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has told Jazz Pharmaceutical it can't approve sodium oxybate (JZP-6) -- also known as GHB -- in its current form for treating fibromyalgia.” View full resource at medpagetoday.com
Most Recently Shared on October 12, 2010 at 1:42 pm By:
Physician Assistants Health News Feed
FDA says it can't approve sodium oxybate (JZP-6), also known as GHB, for treating fibromyalgia: http://bit.ly/dswD7Y
FDA Rejects GHB for Fibromyalgia - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- The FDA has told Jazz Pharmaceutical it can't approve sodium oxybate (JZP-6) -- also known as GHB -- in its current form for treating fibromyalgia.” View full resource at qualitypointtech.net
Most Recently Shared on October 11, 2010 at 5:36 pm By:
FDA Rejects GHB for Fibromyalgia: WASHINGTON (MedPage Today) -- The FDA has told Jazz Pharmaceutical it can't app... http://bit.ly/dB2e13
August 20, 2010: Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement
fda.gov — “August 20, 2010: Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement” View full resource at fda.gov
Most Recently Shared on August 16, 2010 at 11:30 pm By:
Hisham Rana, MD Doctor and Physician
News: On Friday, FDA panel will discuss a new application from Jazz Pharmaceuticals for a fibromyalgia drug http://bit.ly/d9T8SY - #health
FDA Panel Looks at CNS Depressant for Fibromyalgia - QualityPoint Technologies
qualitypointtech.net — “BETHESDA, Md. (MedPage Today) -- A joint FDA advisory committee will meet here Friday to consider whether the narcolepsy drug sodium oxybate (Xyrem) should receive an additional indication to treat fibromyalgia.” View full resource at qualitypointtech.net
Most Recently Shared on August 19, 2010 at 11:21 pm By:
FDA Panel Looks at CNS Depressant for Fibromyalgia: BETHESDA, Md. (MedPage Today) -- A joint FDA advisory committe... http://bit.ly/9l81Vz
FDA panel won't recommend Jazz's treatment for fibromyalgia - Related Stories - AANP SmartBrief
smartbrief.com — “FDA advisers voted 20-2 against endorsing the approval of sodium oxybate, Jazz Pharmaceuticals' fibromyalgia treatment, because the drug's clinical benefit doesn't outweigh its risks of abuse and misuse. "We will carefully consider the input of the committee as we seek to address the needs of fibro--” View full resource at smartbrief.com
Most Recently Shared on August 23, 2010 at 3:30 pm By:
Women In Pain Health Organization
FDA panel won't recommend Jazz's treatment for fibromyalgia http://sbne.ws/r/5qPP
FDA: Pain med could be used for 'date rape' drug - Health - More health news - msnbc.com
msnbc.msn.com — “Jazz Pharmaceuticals has proposed measures to reduce the chances of abuse or errors in drug designed to treat fibromyalgia, a disorder that causes pain and fatigue.” View full resource at msnbc.msn.com
Most Recently Shared on August 18, 2010 at 5:33 pm By:
Physician Assistants Health News Feed
FDA: Pain med could be used as ‘date rape’ http://bit.ly/bBfA9K
FDA: Pain med could be used for 'date rape' drug - Health - More health news - msnbc.com
msnbc.msn.com — “Jazz Pharmaceuticals has proposed measures to reduce the chances of abuse or errors in drug designed to treat fibromyalgia, a disorder that causes pain and fatigue.” View full resource at msnbc.msn.com
Most Recently Shared on August 18, 2010 at 4:25 pm By:
FDA: Pain med could be used for date rape drug: Jazz Pharmaceuticals has proposed measures to reduce the chances o... http://bit.ly/boeyRH
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
Fibromyalgia OW
Organizing fibromyalgia resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
